This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Spectral MD Holdings Gelecekteki Büyüme

Future kriter kontrolleri 5/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Spectral MD Holdings.

Anahtar bilgiler

79.2%

Kazanç büyüme oranı

79.2%

EPS büyüme oranı

Medical Equipment kazanç büyümesi22.9%
Gelir büyüme oranı51.0%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme06 Sep 2023

Gelecekteki son büyüme güncellemeleri

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

AIM:SMD - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20251193431N/A2
12/31/202438-3-10-92
12/31/202326-10-6-62
3/31/202325-6-4-4N/A
12/31/202225-3-1-1N/A
9/30/202223-3-1-1N/A
6/30/202220-4-2-2N/A
3/31/202218-5-3-3N/A
12/31/202115-5-3-3N/A
9/30/202116-400N/A
6/30/202117-322N/A
3/31/202117-133N/A
12/31/202017144N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: SMD is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.4%).

Kazançlar ve Piyasa: SMD is forecast to become profitable over the next 3 years, which is considered above average market growth.

Yüksek Büyüme Kazançları: SMD is expected to become profitable in the next 3 years.

Gelir ve Pazar: SMD's revenue (51% per year) is forecast to grow faster than the UK market (4.1% per year).

Yüksek Büyüme Geliri: SMD's revenue (51% per year) is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if SMD's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin